RITA PRICE: Open Payments
NPI 1528007747 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 15 payments from 6 companies in 2025. Trend: 2023 $1,031 · 2024 $794 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $127 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Organon LLC | 2 | $26 |
| ABBVIE INC. | 1 | $25 |
| LEO Pharma Inc. | 1 | $22 |
Products named: TREMFYA, XOLAIR, DUPIXENT, COSENTYX, VTAMA, SKYRIZI, ANZUPGO.
Industry payments across CA — which companies pay providers there.
